Experiment: 2N88

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.26 mM [U-100% 13C; U-100% 15N] CD3	90% H2O/10% D2O	0.15	6.5	ambient	298
2	3D HNCA	0.26 mM [U-100% 13C; U-100% 15N] CD3	90% H2O/10% D2O	0.15	6.5	ambient	298
3	3D HNCACB	0.26 mM [U-100% 13C; U-100% 15N] CD3	90% H2O/10% D2O	0.15	6.5	ambient	298
4	3D HNCO	0.26 mM [U-100% 13C; U-100% 15N] CD3	90% H2O/10% D2O	0.15	6.5	ambient	298
5	2D 1H-13C HSQC aliphatic	0.26 mM [U-100% 13C; U-100% 15N] CD3	90% H2O/10% D2O	0.15	6.5	ambient	298
6	2D 1H-13C HSQC aromatic	0.26 mM [U-100% 13C; U-100% 15N] CD3	90% H2O/10% D2O	0.15	6.5	ambient	298
7	3D HCCH-TOCSY	0.26 mM [U-100% 13C; U-100% 15N] CD3	90% H2O/10% D2O	0.15	6.5	ambient	298
8	3D HCCH-TOCSY	0.26 mM [U-100% 13C; U-100% 15N] CD3	90% H2O/10% D2O	0.15	6.5	ambient	298
9	3D 1H-13C NOESY aliphatic	0.8 mM [U-100% 13C; U-100% 15N] CD3	90% H2O/10% D2O	0.15	6.5	ambient	298
10	3D 1H-15N NOESY	0.8 mM [U-100% 13C; U-100% 15N] CD3	90% H2O/10% D2O	0.15	6.5	ambient	298
11	3D 1H-13C NOESY aromatic	0.8 mM [U-100% 13C; U-100% 15N] CD3	90% H2O/10% D2O	0.15	6.5	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	800
2	Bruker	AVANCE III	600

NMR Refinement
Method	Details	Software
simulated annealing		CYANA

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	20
Conformers Submitted Total Number	9
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	CYANA	3.0	Guntert, Mumenthaler and Wuthrich
2	refinement	ARIA	1.2	Linge, O'Donoghue and Nilges
3	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
4	chemical shift assignment	CARA		Keller and Wuthrich
5	data analysis	CARA		Keller and Wuthrich
6	peak picking	CARA		Keller and Wuthrich
7	collection	TopSpin		Bruker Biospin
8	geometry optimization	TALOS		Cornilescu, Delaglio and Bax

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.